Romuald Corbau

Chief Tech/Sci/R&D Officer at ADVERUM BIOTECHNOLOGIES, INC.

55 year

Health Technology

Consumer Services

Profile

Romuald Corbau is currently the Chief Scientific Officer at Adverum Biotechnologies, Inc. He previously held the same position at Freeline Therapeutics Holdings Plc from 2020 to 2021.
Additionally, he served as the Chief Scientific Officer at GenEdit, Inc. Dr. Corbau is a graduate of Université des Sciences et Technologies de Lille.

Romuald Corbau active positions

Companies	Position	Start
ADVERUM BIOTECHNOLOGIES, INC.	Chief Tech/Sci/R&D Officer	2024-01-28

All active positions of Romuald Corbau

Former positions of Romuald Corbau

Companies	Position	End
FREELINE THERAPEUTICS HOLDINGS PLC	Chief Tech/Sci/R&D Officer	2021-08-19
GenEdit, Inc. GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA.	Chief Tech/Sci/R&D Officer	-

See the detail of Romuald Corbau's experience

Training of Romuald Corbau

Université des Sciences et Technologies de Lille

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Romuald Corbau's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ADVERUM BIOTECHNOLOGIES, INC.	Health Technology

Private companies	2
GenEdit, Inc. GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA.	Health Technology
Freeline Therapeutics Holdings Plc Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom.	Health Technology